Five electrophysiologists joined Cardiovascular Business editorial advisor Matthew R. Reynolds, MD, SM, for a discussion about how they will deliver quality care to a growing number of atrial fibrillation patients even as the U.S. healthcare system turns its focus from volume to value.

Two physicians received a total of $500,000 in grants from the Heart Rhythm Society (HRS) and Boehringer Ingelheim Pharmaceuticals to support quality improvement research on atrial fibrillation and stroke prevention.

This study builds on the growing body of evidence for managing heart failure using the St. Jude Medical MultiPoint pacing technology for patients not responsive to other therapy options

DUBLIN and SAN FRANCISCO - May 5, 2016 - Medtronic plc (NYSE:MDT) today announced clinical results highlighting the strong safety and performance profile of the miniaturized Micra® Transcatheter Pacing System (TPS) at Heart Rhythm 2016, the Heart Rhythm Society's 37th Annual Scientific Sessions in San Francisco.

The Heart Rhythm Society (HRS) announced it would award up to $500,000 in grants for atrial fibrillation and stroke prevention research aimed at addressing National Quality Improvement priorities.

A disconnect between best care and what Medicare is willing to reimburse for it has put some electrophysiologists and their hospitals in a bind.

Life-Saving Technology Designed for Safety, Stability and Procedural Control.

Months after the U.S. FDA approved a device with the potential to close the source of many atrial fibrillation-related strokes, hospitals, cardiologists and patients find themselves in a holding pattern increasingly common for newly emerging therapies: They are waiting for the CMS to issue a national coverage determination for LAA occlusion.